Platinum based Cancer Drug Industry Research Report 2024

Platinum based Cancer Drug Industry Research Report 2024


Summary

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
According to APO Research, the global Platinum based Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Platinum based Cancer Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Platinum based Cancer Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Platinum based Cancer Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Platinum based Cancer Drug include Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug.
The report will help the Platinum based Cancer Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Platinum based Cancer Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platinum based Cancer Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Platinum based Cancer Drug segment by Type

Cisplatin
Oxaliplatin
Carboplatin
Others
Platinum based Cancer Drug segment by Application

Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Platinum based Cancer Drug Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum based Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Platinum based Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum based Cancer Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Platinum based Cancer Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Platinum based Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Platinum based Cancer Drug Market Size (2019-2030) & (US$ Million)
2.2.2 Global Platinum based Cancer Drug Sales (2019-2030)
2.2.3 Global Platinum based Cancer Drug Market Average Price (2019-2030)
2.3 Platinum based Cancer Drug by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Cisplatin
2.3.3 Oxaliplatin
2.3.4 Carboplatin
2.3.5 Others
2.4 Platinum based Cancer Drug by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Colorectal Cancer
2.4.3 Ovarian Cancer
2.4.4 Lung Cancer
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Platinum based Cancer Drug Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Platinum based Cancer Drug Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Platinum based Cancer Drug Revenue of Manufacturers (2019-2024)
3.4 Global Platinum based Cancer Drug Average Price by Manufacturers (2019-2024)
3.5 Global Platinum based Cancer Drug Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Platinum based Cancer Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Platinum based Cancer Drug, Product Type & Application
3.8 Global Manufacturers of Platinum based Cancer Drug, Date of Enter into This Industry
3.9 Global Platinum based Cancer Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Sanofi
4.1.1 Sanofi Company Information
4.1.2 Sanofi Business Overview
4.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Platinum based Cancer Drug Product Portfolio
4.1.5 Sanofi Recent Developments
4.2 Hengrui Medicine
4.2.1 Hengrui Medicine Company Information
4.2.2 Hengrui Medicine Business Overview
4.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Hengrui Medicine Platinum based Cancer Drug Product Portfolio
4.2.5 Hengrui Medicine Recent Developments
4.3 ASK Pharma
4.3.1 ASK Pharma Company Information
4.3.2 ASK Pharma Business Overview
4.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.3.4 ASK Pharma Platinum based Cancer Drug Product Portfolio
4.3.5 ASK Pharma Recent Developments
4.4 Yi Bai Pharmaceutical
4.4.1 Yi Bai Pharmaceutical Company Information
4.4.2 Yi Bai Pharmaceutical Business Overview
4.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio
4.4.5 Yi Bai Pharmaceutical Recent Developments
4.5 Qilu Pharmaceutical
4.5.1 Qilu Pharmaceutical Company Information
4.5.2 Qilu Pharmaceutical Business Overview
4.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio
4.5.5 Qilu Pharmaceutical Recent Developments
4.6 Teva
4.6.1 Teva Company Information
4.6.2 Teva Business Overview
4.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Teva Platinum based Cancer Drug Product Portfolio
4.6.5 Teva Recent Developments
4.7 Pfizer
4.7.1 Pfizer Company Information
4.7.2 Pfizer Business Overview
4.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Pfizer Platinum based Cancer Drug Product Portfolio
4.7.5 Pfizer Recent Developments
4.8 Dr Reddy's Laboratories
4.8.1 Dr Reddy's Laboratories Company Information
4.8.2 Dr Reddy's Laboratories Business Overview
4.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio
4.8.5 Dr Reddy's Laboratories Recent Developments
4.9 Mylan
4.9.1 Mylan Company Information
4.9.2 Mylan Business Overview
4.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Mylan Platinum based Cancer Drug Product Portfolio
4.9.5 Mylan Recent Developments
4.10 Sun Pharma
4.10.1 Sun Pharma Company Information
4.10.2 Sun Pharma Business Overview
4.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Sun Pharma Platinum based Cancer Drug Product Portfolio
4.10.5 Sun Pharma Recent Developments
4.11 Novartis
4.11.1 Novartis Company Information
4.11.2 Novartis Business Overview
4.11.3 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Novartis Platinum based Cancer Drug Product Portfolio
4.11.5 Novartis Recent Developments
4.12 Debiopharm
4.12.1 Debiopharm Company Information
4.12.2 Debiopharm Business Overview
4.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Debiopharm Platinum based Cancer Drug Product Portfolio
4.12.5 Debiopharm Recent Developments
4.13 Accord Healthcare
4.13.1 Accord Healthcare Company Information
4.13.2 Accord Healthcare Business Overview
4.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Accord Healthcare Platinum based Cancer Drug Product Portfolio
4.13.5 Accord Healthcare Recent Developments
4.14 SK Chemicals
4.14.1 SK Chemicals Company Information
4.14.2 SK Chemicals Business Overview
4.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
4.14.4 SK Chemicals Platinum based Cancer Drug Product Portfolio
4.14.5 SK Chemicals Recent Developments
5 Global Platinum based Cancer Drug Market Scenario by Region
5.1 Global Platinum based Cancer Drug Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Platinum based Cancer Drug Sales by Region: 2019-2030
5.2.1 Global Platinum based Cancer Drug Sales by Region: 2019-2024
5.2.2 Global Platinum based Cancer Drug Sales by Region: 2025-2030
5.3 Global Platinum based Cancer Drug Revenue by Region: 2019-2030
5.3.1 Global Platinum based Cancer Drug Revenue by Region: 2019-2024
5.3.2 Global Platinum based Cancer Drug Revenue by Region: 2025-2030
5.4 North America Platinum based Cancer Drug Market Facts & Figures by Country
5.4.1 North America Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Platinum based Cancer Drug Sales by Country (2019-2030)
5.4.3 North America Platinum based Cancer Drug Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Platinum based Cancer Drug Market Facts & Figures by Country
5.5.1 Europe Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Platinum based Cancer Drug Sales by Country (2019-2030)
5.5.3 Europe Platinum based Cancer Drug Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Platinum based Cancer Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Platinum based Cancer Drug Sales by Country (2019-2030)
5.6.3 Asia Pacific Platinum based Cancer Drug Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Platinum based Cancer Drug Market Facts & Figures by Country
5.7.1 Latin America Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Platinum based Cancer Drug Sales by Country (2019-2030)
5.7.3 Latin America Platinum based Cancer Drug Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Platinum based Cancer Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Platinum based Cancer Drug Sales by Country (2019-2030)
5.8.3 Middle East and Africa Platinum based Cancer Drug Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Platinum based Cancer Drug Sales by Type (2019-2030)
6.1.1 Global Platinum based Cancer Drug Sales by Type (2019-2030) & (K Units)
6.1.2 Global Platinum based Cancer Drug Sales Market Share by Type (2019-2030)
6.2 Global Platinum based Cancer Drug Revenue by Type (2019-2030)
6.2.1 Global Platinum based Cancer Drug Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Platinum based Cancer Drug Revenue Market Share by Type (2019-2030)
6.3 Global Platinum based Cancer Drug Price by Type (2019-2030)
7 Segment by Application
7.1 Global Platinum based Cancer Drug Sales by Application (2019-2030)
7.1.1 Global Platinum based Cancer Drug Sales by Application (2019-2030) & (K Units)
7.1.2 Global Platinum based Cancer Drug Sales Market Share by Application (2019-2030)
7.2 Global Platinum based Cancer Drug Revenue by Application (2019-2030)
7.2.1 Global Platinum based Cancer Drug Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Platinum based Cancer Drug Revenue Market Share by Application (2019-2030)
7.3 Global Platinum based Cancer Drug Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Platinum based Cancer Drug Value Chain Analysis
8.1.1 Platinum based Cancer Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Platinum based Cancer Drug Production Mode & Process
8.2 Platinum based Cancer Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Platinum based Cancer Drug Distributors
8.2.3 Platinum based Cancer Drug Customers
9 Global Platinum based Cancer Drug Analyzing Market Dynamics
9.1 Platinum based Cancer Drug Industry Trends
9.2 Platinum based Cancer Drug Industry Drivers
9.3 Platinum based Cancer Drug Industry Opportunities and Challenges
9.4 Platinum based Cancer Drug Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings